Stay updated with breaking news from Stem Cell Transplantation Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BIOSENIC Euronext Brussels and Paris: BIOS), the company specialized in serious autoimmune inflammatory diseases and cell repair, today announces an update on its systemic autoimmune disease... | November 9, 2022
REGULATED INFORMATION The autoimmune disease platform has completed a successful phase IIb trial targeting cGVHD (chronic Graft vs Host Disease), with a...
Versant Ventures Launches Cimeio Therapeutics with $50 Million Series A - read this article along with other careers information, tips and advice on BioSpace